Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LINC CARE: Osilodrostat in Cushing's Syndrome with Hypertension
NCT07247162Phase 4Recruiting
- Sponsor
- Recordati SpA
- Start
- Aug 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 4 trial of osilodrostat in Cushing syndrome, hypertension (HTN), Cushing's syndrome, sponsored by Recordati SpA. Started Aug 2026; status: recruiting.
02
Drugs
osilodrostat
03
Conditions
Cushing syndromehypertension (HTN)Cushing's syndrome
Beyond the preview
Go deeper on NCT07247162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07247162.